Anthrax Vaccine Adsorbed, Adjuvanted (Emergent )

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug NameAnthrax Vaccine Adsorbed, Adjuvanted (Emergent )
Drug Alias NameBioThrax + agatolimodThird-generation anthrax vaccine candidate (BioThrax + CPG 7909) - Emergent BioSolutionsNuThraxCYFENDUSAV-7909
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAnthrax
Global Approved IndicationsAnthrax
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2023/07/20
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEmergent
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc
Inactive CompaniesUs Department Of Health And Human ServicesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsAnthrax
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A